BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 20544928)

  • 21. Combined fused in sarcoma-positive (FUS+) basophilic inclusion body disease and atypical tauopathy presenting with an amyotrophic lateral sclerosis/motor neurone disease (ALS/MND)-plus phenotype.
    Wharton SB; Verber NS; Wagner BE; Highley JR; Fillingham DJ; Waller R; Strand K; Ince PG; Shaw PJ
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):586-596. PubMed ID: 30659642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
    Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
    J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.
    Hou L; Jiao B; Xiao T; Zhou L; Zhou Z; Du J; Yan X; Wang J; Tang B; Shen L
    Sci Rep; 2016 Sep; 6():32478. PubMed ID: 27604643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
    Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis.
    Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
    Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
    Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
    Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
    Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.
    Lattante S; Rouleau GA; Kabashi E
    Hum Mutat; 2013 Jun; 34(6):812-26. PubMed ID: 23559573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical FTLD-FUS associated with ALS-TDP: a case report.
    Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
    Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of the FUS gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin.
    Zou ZY; Peng Y; Feng XH; Wang XN; Sun Q; Liu MS; Li XG; Cui LY
    Eur J Neurol; 2012 Jul; 19(7):977-83. PubMed ID: 22340366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.
    Ince PG; Highley JR; Kirby J; Wharton SB; Takahashi H; Strong MJ; Shaw PJ
    Acta Neuropathol; 2011 Dec; 122(6):657-71. PubMed ID: 22105541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo FUS mutations in 2 Korean patients with sporadic amyotrophic lateral sclerosis.
    Kim YE; Oh KW; Kwon MJ; Choi WJ; Oh SI; Ki CS; Kim SH
    Neurobiol Aging; 2015 Mar; 36(3):1604.e17-9. PubMed ID: 25457557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Amyotrophic lateral sclerosis (ALS) with the mutations in the fused in sarcoma/translocated in liposarcoma gene].
    Aoki M
    Rinsho Shinkeigaku; 2013; 53(11):1080-3. PubMed ID: 24291885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS.
    Kwon MJ; Baek W; Ki CS; Kim HY; Koh SH; Kim JW; Kim SH
    Neurobiol Aging; 2012 May; 33(5):1017.e17-23. PubMed ID: 22244934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of amyotrophic lateral sclerosis.
    Liscic RM; Breljak D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
    Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
    Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
    Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
    Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.
    Qiu H; Lee S; Shang Y; Wang WY; Au KF; Kamiya S; Barmada SJ; Finkbeiner S; Lui H; Carlton CE; Tang AA; Oldham MC; Wang H; Shorter J; Filiano AJ; Roberson ED; Tourtellotte WG; Chen B; Tsai LH; Huang EJ
    J Clin Invest; 2014 Mar; 124(3):981-99. PubMed ID: 24509083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.